QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hamilton-Reeves, J. M. Articles by Kurzer, M. S. Search for Related Content PubMed PubMed Citation Articles by Hamilton-Reeves, J. M. Articles by Kurzer, M. S.

---

Nutrition and Disease

Soy Protein Isolate Increases Urinary Estrogens and the Ratio of 2:16-Hydroxyestrone in Men at High Risk of Prostate Cancer^1,2

³ Department of Food Science and Nutrition, University of Minnesota, St. Paul, MN 55108; ⁴ Division of Biostatistics in the School of Public Health, University of Minnesota, Minneapolis, MN 55455; ⁵ Department of Urologic Surgery, University of Minnesota, Minneapolis, MN 55455; and Department of Urology, Veterans Administration Medical Center, Minneapolis, MN 55417

^* To whom correspondence should be addressed. E-mail: mkurzer{at}umn.edu.

Specific estrogen metabolites may initiate and promote hormone-related cancers. In epidemiological studies, significantly lower excretion of urinary estradiol (E2) and lower ratio of urinary 2-hydroxy estrogens to 16-hydroxyestrone (2:16 OH-E1) have been reported in prostate cancer cases compared to controls. Although soy supplementation has been shown to increase the ratio 2:16 OH-E1 in women, no studies to our knowledge have investigated the effects of soy supplementation on estrogen metabolism in men. The objective of this randomized controlled trial was to determine the effects of soy protein isolate consumption on estrogen metabolism in men at high risk for developing advanced prostate cancer. Fifty-eight men supplemented their habitual diets with 1 of 3 protein isolates: 1) isoflavone-rich soy protein isolate (SPI+) (107 mg isoflavones/d); 2) alcohol-washed soy protein isolate (SPI–) (<6 mg isoflavones/d); or 3) milk protein isolate (MPI), each providing 40 g protein/d. At 0, 3, and 6 mo of supplementation, the urinary estrogen metabolite profile was measured by GC-MS. Both soy groups had higher E2 excretion than the MPI group at 3 and 6 mo. After 6 mo of supplementation, the SPI+ group had a significantly higher urinary 2:16 OH-E1 ratio than the MPI group. Increased urinary E2 excretion and 2:16 OH-E1 ratio in men consuming soy protein isolate are consistent with studies in postmenopausal women and suggest that soy consumption may be beneficial in men at high risk of progressing to advanced prostate cancer as a result of effects on endogenous estrogen metabolism.